Butterfly Network, Inc. (BFLY) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript

Why It Matters

Semiconductor ultrasound could democratize diagnostic imaging, driving cost efficiencies and expanding access in hospitals and remote clinics, reshaping the $10 billion ultrasound industry.

Key Takeaways

• Butterfly's chip replaces multiple crystal probes with a single semiconductor array
• Semiconductor ultrasound reduces device cost and expands point‑of‑care access
• CEO emphasized rapid adoption since 2011 and scaling production
• Company targets $1B+ imaging market by 2030
• Analyst expects revenue CAGR above 30% through 2028

Pulse Analysis

Butterfly Network’s semiconductor ultrasound chip marks a paradigm shift in medical imaging. By integrating a silicon‑based transducer array onto a single chip, the company eliminates the need for interchangeable crystal probes, slashing hardware costs and simplifying device design. This innovation not only reduces the price point for clinicians but also enables truly portable scanners that can be deployed in emergency rooms, primary‑care offices, and underserved regions, accelerating the move toward point‑of‑care diagnostics.

The global ultrasound market, valued at roughly $10 billion, is poised for disruption as providers seek affordable, high‑resolution imaging solutions. Butterfly’s chip technology offers comparable image quality to traditional systems while delivering a fraction of the capital expense, positioning the firm to win market share from legacy manufacturers. Regulatory clearances across major markets and growing partnerships with health systems underscore the scalability of the platform. As telehealth and remote monitoring expand, demand for compact, network‑connected scanners is expected to rise sharply, creating a tailwind for Butterfly’s growth trajectory.

Financially, the conference presentation reinforced the company’s aggressive revenue outlook, targeting over $1 billion in market penetration by 2030 and projecting a compound annual growth rate exceeding 30% through 2028. Analyst sentiment at William Blair highlighted the scalability of the semiconductor supply chain and the potential for margin expansion as volume ramps. Investors are watching closely for execution milestones, including new product launches and international expansion, which could translate into a premium valuation as Butterfly continues to redefine the economics of diagnostic imaging.